SEREVENT - 68258-8961-6 - (salmeterol xinafoate)

Alphabetical Index


Drug Information of SEREVENT

Product NDC: 68258-8961
Proprietary Name: SEREVENT
Non Proprietary Name: salmeterol xinafoate
Active Ingredient(s): 50    ug/1 & nbsp;   salmeterol xinafoate
Administration Route(s): ORAL; RESPIRATORY (INHALATION)
Dosage Form(s): POWDER, METERED
Coding System: National Drug Codes(NDC)

Labeler Information of SEREVENT

Product NDC: 68258-8961
Labeler Name: Dispensing Solutions, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020692
Marketing Category: NDA
Start Marketing Date: 19971125

Package Information of SEREVENT

Package NDC: 68258-8961-6
Package Description: 60 POWDER, METERED in 1 INHALER (68258-8961-6)

NDC Information of SEREVENT

NDC Code 68258-8961-6
Proprietary Name SEREVENT
Package Description 60 POWDER, METERED in 1 INHALER (68258-8961-6)
Product NDC 68258-8961
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name salmeterol xinafoate
Dosage Form Name POWDER, METERED
Route Name ORAL; RESPIRATORY (INHALATION)
Start Marketing Date 19971125
Marketing Category Name NDA
Labeler Name Dispensing Solutions, Inc.
Substance Name SALMETEROL XINAFOATE
Strength Number 50
Strength Unit ug/1
Pharmaceutical Classes Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]

Complete Information of SEREVENT


General Information